HEK-293t,
SW480,
SW620,
MCF10A and
MDA-MB-231 were purchased from ATCC collection (Middlesex, UK). Human Fibroblasts correspond to early passage fibroblasts isolated from neonatal human foreskin as described previously (Baus, 2003 (
link); Dazard, 2000 ).
MDA-MB-231-
D3H2LN was a Bioware Cell line purchased from Caliper LifeScience (Villepinte, France). Cells were regularly checked for mycoplasma contamination by using
Mycoalert Detection Kit (#LT07-318) from Lonza (Levallois, France).
HEK-293t,
SW480,
SW620,
MDA-MB-231 and
D3H2LN were grown in DMEM supplemented with 10% FBS, 1 mM sodium pyruvate and
antibiotics/glutamine (Invitrogen, Thermo Fisher, Illkirch, France).
MCF10A cells were cultured in DMEM/F12 with 5% horse serum (Invitrogen, 1 mM sodium pyruvate,
EGF (20 ng/ml, PEPROTECH, Neuilly-Sur-Seine, France),
Hydrocortizone (500 ng/ml),
cholera toxin (100 ng/ml),
Insulin (10 μg/ml) (Sigma Aldrich, Saint-Quentin Fallavier, France) and
antibiotics/glutamine (Invitrogen).
Human Fibroblasts were grown in MEM supplemented with 10% FCS,
antibiotics/glutamine (Invitrogen).
Vera J., Lartigue L., Vigneron S., Gadea G., Gire V., Del Rio M., Soubeyran I., Chibon F., Lorca T, & Castro A. (2015). Greatwall promotes cell transformation by hyperactivating AKT in human malignancies. eLife, 4, e10115.